Effect of second-generation antiepileptic drugs on diplopia: A meta-analysis of placebo-controlled studies
暂无分享,去创建一个
G. Zhen | Suiqiang Zhu | Huicong Kang | Wensheng Qu | Zheng Xue | Xiaoqing Hu | Haiyan Han
[1] M. Baulac,et al. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures , 2007, Epilepsy Research.
[2] T. Yamauchi,et al. Treatment of partial seizures with gabapentin: Double‐blind, placebo‐controlled, parallel‐group study * , 2006, Psychiatry and clinical neurosciences.
[3] Jing-Jane Tsai,et al. Efficacy and Safety of Levetiracetam (up to 2000 mg/day) in Taiwanese Patients with Refractory Partial Seizures: A Multicenter, Randomized, Double‐blind, Placebo‐controlled Study , 2006, Epilepsia.
[4] C. Elger,et al. Pregabalin Add‐on Treatment in Patients with Partial Seizures: A Novel Evaluation of Flexible‐dose and Fixed‐dose Treatment in a Double‐blind, Placebo‐controlled Study , 2005, Epilepsia.
[5] B. Uthman,et al. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy , 2005, Neurology.
[6] S. Arroyo,et al. Pregabalin Add‐on Treatment: A Randomized, Double‐blind, Placebo‐controlled, Dose–Response Study in Adults with Partial Seizures , 2004, Epilepsia.
[7] R. Ramsay,et al. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. 1993. , 2001, Neurology.
[8] C. Elger,et al. Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy , 2000, Epilepsia.
[9] J. Bruni,et al. Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study , 2000, Seizure.
[10] Martin A. Samuels,et al. ADAMS AND VICTOR'S PRINCIPLES OF NEUROLOGY , 2010, Neurology.
[11] S. Berkovic,et al. A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizures , 1996, Seizure.
[12] G. Pledger,et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages , 1996, Neurology.
[13] F. Matsuo,et al. Lamotrigine: A six-month, placebo-controlled, safety and tolerance study , 1995 .
[14] T. Feuerstein,et al. Gabapentin (Neurontin) as Add‐on Therapy in Patients with Partial Seizures: A Double‐Blind, Placebo‐Controlled Study , 1994, Epilepsia.
[15] R. Mattson,et al. Lamotrigine Therapy for Partial Seizures: A Multicenter, Placebo‐Controlled, Double‐Blind, Cross‐Over Trial , 1994, Epilepsia.
[16] F. Matsuo,et al. Placebo‐controlled study of the efficacy and safety of lamotrigine in patients with partial seizures , 1993, Neurology.
[17] S. Berkovic,et al. Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[18] G. Baker,et al. Outcomes of Add‐on Treatment with Lamotrigine in Partial Epilepsy , 1993, Epilepsia.
[19] C. Binnie,et al. Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy , 1989, Epilepsy Research.
[20] S. Shorvon,et al. [Medical treatment of epilepsy : monotherapy versus polytherapy (author's transl)]. , 1981, La Nouvelle presse medicale.
[21] S. Shorvon,et al. Monotherapy or polytherapy for epilepsy? , 1981, Epilepsia.
[22] S. Shorvon,et al. Monotherapy or Poly therapy for Epilepsy? , 1981 .